|
1
|
Molina E and Hernandez A: Clinical
manifestations of primary hepatic angiosarcoma. Dig Dis Sci.
48:677–682. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chien CY, Hwang CC, Yeh CN, Chen HY, Wu
JT, Cheung CS, Lin CL, Yen CL, Wang WY and Chiang KC: Liver
angiosarcoma, a rare liver malignancy, presented with
intraabdominal bleeding due to rupture - a case report. World J
Surg Oncol. 10:232012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Young RJ, Brown NJ, Reed MW, Hughes D and
Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–991. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang NC, Wann SR, Chang HT, Lin SL, Wang
JS and Guo HR: Arsenic, vinyl chloride, viral hepatitis, and
hepatic angiosarcoma: A hospital-based study and review of
literature in Taiwan. BMC Gastroenterol. 11:1422011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ho S-Y, Tsai C-C, Tsai Y-C and Guo H-R:
Hepatic angiosarcoma presenting as hepatic rupture in a patient
with long-term ingestion of arsenic. J Formos Med Assoc.
103:374–379. 2004.PubMed/NCBI
|
|
6
|
Wang TH, Pan ZG and Ren ZG: Rare primary
liver malignant tumor. Fudan Univ J Med Sci. 36:221–224. 2009.
|
|
7
|
Baxter PJ: The British hepatic
angiosarcoma register. Environ Health Perspect. 41:115–116. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vianna NJ, Brady JA and Cardamone AT:
Epidemiology of angiosarcoma of liver in New York State. N Y State
J Med. 81:895–899. 1981.PubMed/NCBI
|
|
9
|
Cawich SO, Johnson PB, Shah S, et al:
Overcoming obstacles to establish a multidisciplinary team approach
to hepatobiliary diseases: a working model in a Caribbean setting.
J Multidiscip Healthc. 7:227–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Locker GY, Doroshow JH, Zwelling LA and
Chabner BA: The clinical features of hepatic angiosarcoma: A report
of four cases and a review of the English literature. Medicine
(Baltimore). 58:48–64. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Timaran CH, Grandas OH and Bell JL:
Hepatic angiosarcoma: Long-term survival after complete surgical
removal. Am Surg. 66:1153–1157. 2000.PubMed/NCBI
|
|
12
|
Poggio JL, Nagorney DM, Nascimento AG,
Rowland C, Kay P, Young RM and Donohue JH: Surgical treatment of
adult primary hepatic sarcoma. Br J Surg. 87:1500–1505. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jaffe BM, Donegan WL, Watson F and Spratt
JS Jr: Factors influencing survival in patients with untreated
hepatic metastases. Surg Gynecol Obstet. 127:1–11. 1968.PubMed/NCBI
|
|
14
|
Tsai CC, Hsieh JF, Han SJ and Mo LR:
Hemoperitoneum secondary to biopsy of the hepatic angiosarcoma.
Chin J Radiol. 24:37–40. 1999.
|
|
15
|
Lee SW, Song CY, Gi YH, Kang SB, Kim YS,
Nam SW, Lee DS and Kim JO: Hepatic angiosarcoma manifested as
recurrent hemoperitoneum. World J Gastroenterol. 14:2935–2938.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Falk H, Herbert JT, Edmonds L, Heath CW
Jr, Thomas LB and Popper H: Review of four cases of childhood
hepatic angiosarcoma - elevated environmental arsenic exposure in
one case. Cancer. 47:382–391. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Almogy G, Lieberman S, Gips M, Pappo O,
Edden Y, Jurim O, Simon Slasky B, Uzieli B and Eid A: Clinical
outcomes of surgical resections for primary liver sarcoma in
adults: Results from a single centre. Eur J Surg Oncol. 30:421–427.
2004. View Article : Google Scholar : PubMed/NCBI
|
